E-18 Corp. underwent a name change to Protectus Medical Devices, Inc. ("Protectus Medical Devices") and announced that its trading symbol as quoted on the OTC Bulletin Board will change from (OTCBB: ETEN) to (OTCBB: PTMD) effective today, Monday, October 26, 2009. Protectus Medical Devices’ common stock will trade under the new CUSIP No. 74369Y105.

The Company’s name change to Protectus Medical Devices and new ticker will be reflected in SEC filings and all future corporate communications with the investor community, including press releases and the company’s website: www.protectusmedical.com.

"In order to more accurately reflect our Company’s broad initiatives to develop our unique, self-sheathing hypodermic safety syringe and related products, we have changed our corporate name to Protectus Medical Devices and our symbol to PTMD," said Dr. John Salstrom, President and CEO. "We look forward to updating our loyal shareholders and prospective investors on Protectus’ exciting developments in the coming weeks and months."

Protectus Medical Devices is committed to the vision of significantly reducing or eliminating accidental needlestick injuries that have plagued the healthcare workplace for decades. The Company's lead product, the Protectus Medical Safety Syringe, is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike.

More information about Protectus Medical Devices, Inc. may be found at the Company's corporate website, as well as its investor relations portal: www.trilogy-capital.com/autoir/eten_autoir.html.

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)

Protectus Medical Devices, Inc. (formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.

Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Protectus Medical Devices, Inc. (formerly, E-18 Corp.) can be found in the filings of Protectus Medical Devices, Inc. with the U.S. Securities and Exchange Commission.